Sign in

CIK 0001863127

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Tyra Biosciences, Inc.

Sign in to watch
Ticker
TYRA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
831476348
Phone
+1 619-728-4760
Business address
2656 STATE STREET, CARLSBAD, CA, 92008
Open-market buys, last 90 days
$20,000
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$20,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Verjee Rehan +$20K Director 1 filing
Date Insider Transaction Shares Price Value Owned after
2022-03-15 Swanson Ronald V. Chief Scientific Officer Grant or award +3,125 $8.53 $27K 273,254
2022-03-15 Patel Piyush R. Chief Development Officer Grant or award +2,408 $8.53 $21K 137,472
2022-03-15 Hudkins Robert L. Chief Technology Officer Grant or award +2,408 $8.53 $21K 272,536
2022-03-15 Harris Todd Chief Executive Officer Grant or award +3,125 $8.53 $27K 1,699,468
2021-12-17 Boxer Capital, LLC 10% owner Purchase +125,000 $13.12 $1.6M 6,448,359
2021-11-02 van den Boom Esther Chief Financial Officer Grant or award · Stock Option (Right to Buy) +83,626 83,626
2021-11-02 van den Boom Esther Chief Financial Officer Grant or award · Stock Option (Right to Buy) +7,964 7,964
2021-11-02 van den Boom Esther Chief Financial Officer Grant or award · Stock Option (Right to Buy) +7,964 7,964
2021-11-02 Patel Piyush R. Chief Development Officer Grant or award · Stock Option (Right to Buy) +83,626 83,626
2021-11-02 Patel Piyush R. Chief Development Officer Grant or award · Stock Option (Right to Buy) +7,964 7,964
2021-11-02 Patel Piyush R. Chief Development Officer Grant or award · Stock Option (Right to Buy) +7,964 7,964
2021-11-02 Tada Hiroomi Chief Medical Officer Grant or award · Stock Option (Right to Buy) +83,626 83,626
2021-11-02 Tada Hiroomi Chief Medical Officer Grant or award · Stock Option (Right to Buy) +7,964 7,964
2021-11-02 Tada Hiroomi Chief Medical Officer Grant or award · Stock Option (Right to Buy) +7,964 7,964
2021-11-02 Hudkins Robert L. Chief Technology Officer Grant or award · Stock Option (Right to Buy) +83,626 83,626
2021-11-02 Hudkins Robert L. Chief Technology Officer Grant or award · Stock Option (Right to Buy) +7,964 7,964
2021-11-02 Hudkins Robert L. Chief Technology Officer Grant or award · Stock Option (Right to Buy) +7,964 7,964
2021-11-02 Swanson Ronald V. Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +83,626 83,626
2021-11-02 Swanson Ronald V. Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +7,964 7,964
2021-11-02 Swanson Ronald V. Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +7,964 7,964

Page 18 of 21 · 417 trades